About 500 reports

  • Global Cardiovascular Drugs Market, Historic and Forecast, Split By Segment, 2012 - 2020
  • PERSONALIZED MEDICINE FOR TREATMENT OF CARDIOVASCULAR DISORDERS

Sanofi' s growth strategy aims at innovating better cure for genetic cardiovascular diseases.

  • Cardiovascular Disease
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Market drivers
  • Geographical segmentation

Aging is one of the risk factors for cardiovascular diseases.

  • Cardiovascular Disease
  • World
  • Cardinal Health, Inc.
  • CONMED Corporation
  • Medtronic, Inc.
  • CARDIOVASCULAR DISEASE THERAPEUTICS MARKET, GLOBAL, PIPELINE FOR CARDIOVASCULAR DISEASES BY
  • A) Global cardiovascular disease market split
  • Cardiovascular Disease
  • World
  • Market Size
  • Novartis AG
  • Sanofi S.A.
  • CARDIOVASCULAR DISEASE SEGMENT TO ACCOUNT FOR THE LARGEST
  • CARDIOVASCULAR DISEASE APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • Cardiovascular Disease
  • Market Size
  • Compumedics Limited
  • Deltex Medical Group plc
  • Getinge Group
  • GLOBAL DEATHS FROM CARDIOVASCULAR DISEASES, 2015
  • U.S.: PERCENTAGE OF CAUSES OF HEART FAILURE RELATED
  • Cardiovascular Disease
  • World
  • Market Size
  • Collagen Solutions plc
  • Jellagen Pty Ltd
  • HIGHLIGHTS
  • INCREASE IN INCIDENCE OF CARDIAC DISORDERS AND RISE IN OLDER POPULATION
  • Blood Device
  • Cardiovascular Disease
  • World
  • Omron Corporation
  • Welch Allyn Inc.
  • 5.3.1 Cardiovascular Disease
  • Cardiovascular Disease Therapeutics Market, Global,
  • Cardiovascular Disease
  • World
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Diabetes complications
  • MAJOR COMPLICATIONS OF DIABETES

The treatment of cardiovascular diseases cost a huge amount to the nation.

  • Cardiovascular Disease
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • CARDIAC PACEMAKERS MARKET IN AMERICAS
  • OVERVIEW

In the UK, hospital admission for cardiovascular diseases increased due to increased cardiovascular disease prescriptions and operations over the last few decades making it second leading cause of death in the year 2014.

  • Cardiovascular Disease
  • United States
  • Forecast
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Diabetes complications
  • OTHER PROMINENT VENDORS

Diabetes acts as one of the major factors leading to cardiovascular diseases.

  • Beta-Blocker
  • Cardiovascular Disease
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • By Patient Type
  • By Patient Type

IN ARGENTINA, CARDIOVASCULAR DISEASES CONTRIBUTE TO ##% MORTALITY.

  • Cardiovascular Disease
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Abiomed, Inc.
  • Radiofrequency ablation market in EMEA 2016-2021 ($ millions)
  • RADIOFREQUENCY ABLATION MARKET IN EMEA

In 2014, Europe recorded four million deaths related to cardiovascular diseases.

  • Cardiovascular Disease
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Stryker Corporation
  • TOTAL NUMBER OF HOSPITALS IN US
  • LIST OF ABBREVIATIONS

Cardiovascular diseases accounts for highest patient pool in the country, after HIV/ AIDS.

  • Cardiovascular Disease
  • Boston Scientific Corporation
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Teleflex Incorporated
  • EP DIAGNOSTIC CATHETERS MARKET IN AMERICAS
  • GLOBAL ADVANCED EP DIAGNOSTIC CATHETERS MARKET

India: Treatment of chronic disorders such as cardiovascular diseases in ASCs is a growing trend in India.

  • Cardiology
  • Cardiovascular Disease
  • Electrophysiology Device
  • World
  • Biosense Webster, Inc.
  • PERCENTAGE USE OF PRESCRIPTION CHOLESTEROL-LOWERING MEDICATION IN US FOR VARIOUS INDICATIONS 2015
  • Cardiovascular Disease
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Growing demand from emerging markets
  • Market drivers

Cholesterol is the primary risk factor for cardiovascular diseases.

  • Cardiovascular Disease
  • World
  • Forecast
  • Archer Daniels Midland Company
  • Cargill Inc.
  • Thoracic surgery market in EMEA
  • Rise in incidence of cardiac disorders and increase in aging population
  • Cardiovascular Disease
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Sorin S.p.A.
  • GLOBAL ENDOVASCULAR GRAFTS MARKET

The leading cause behind the worldwide deaths is CVDs Cardiovascular disease, the common conditions associated with it is stenosis or occlusion of blood vessels.

  • Cardiovascular Disease
  • Cook Medical, Inc.
  • Lombard Medical Technologies PLC
  • Medtronic, Inc.
  • Terumo Corporation
  • 3.3 FACTORS INFLUENCING MARKET
  • Application

In cardiovascular diseases ablation finds its application mainly in atrial fibrillation and tachycardia.

  • Cardiovascular Disease
  • World
  • Market Size
  • Boston Scientific Corporation
  • CONMED Corporation
  • PUBLIC AWARENESS ABOUT CARDIOVASCULAR DISEASES (CVDS)
  • Cardiac Management
  • Cardiovascular Disease
  • World
  • Forecast
  • Medtronic, Inc.
  • 6.1.1 GROWING AGING POPULATION

Aging population are more prone to coagulation disorders, cardiovascular disease and surgeries such as knee and hip replacement surgeries.

  • Cardiovascular Disease
  • World
  • Market Size
  • Bayer AG
  • Daiichi Sankyo Company
  • Partnership agreements...

In May 2016, MyoKardia' s MYK-##, a novel drug therapy targeting genetic cardiovascular disease (CVD), received the orphan drug designation by the US FDA, for the treatment of symptomatic obstructive HCM.

  • Cardiovascular Disease
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Description and impact on the market
  • KEY MARKET HIGHLIGHTS

High cholesterol levels can cause cardiovascular diseases (CVD) such as stroke and atherosclerosis.

  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC

The 2018-2023 World Outlook for Cardiovascular Disease (CVD) Diagnostics ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cardiovascular Disease
  • Chronic Disease
  • Demand

The 2018-2023 World Outlook for Cardiovascular Disease (CVD) Treatments ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cardiovascular Disease
  • Chronic Disease
  • Pathology
  • Demand
  • Incidences of Cardiovascular Diseases
  • PERCENTAGE OF POPULATION SUFFERING FROM CARDIOVASCULAR DISEASE IN USA (2009-2012)
  • Cardiovascular Disease
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • CADS

Currently, MI drug eluting balloons are used for the treatment of cardiovascular diseases (CVDs) and represent lower risks compared with conventional procedures.

  • Cardiovascular Disease
  • B. Braun Medical
  • C.R. Bard, Inc.
  • Cook Medical, Inc.
  • Medtronic, Inc.

Treatment for cardiovascular diseases in ASCs is a growing trend in India.

  • Cardiovascular Disease
  • Abiomed, Inc.
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Thoratec Corporation
  • INCREASING AWARENESS ABOUT CARDIOVASCULAR DISEASES (CVDS)
  • GROWTH OF AGING POPULATION
  • Cardiovascular Disease
  • Medical Equipment
  • World
  • Forecast
  • Medtronic, Inc.

Global ECG Market

3864 4250 3284
  • 3.1 MARKET DRIVERS

In 2014, a total of ##, ## deaths were due to cardiovascular diseases.

  • Cardiovascular Disease
  • World
  • Cardiac Science Corporation
  • GE Healthcare Limited
  • Welch Allyn Inc.